HOXB9 and colorectal carcinoma: Nevertheless, due to the complexity and heterogeneity of the HOX gene family, further well-conducted and even larger-scale or multicentre clinical and preclinical studies with robust methodology are needed to elucidate the role of each gene and especially HOXB9 in CRC thus determining the validity of their role as potential biomarkers or therapeutic targets in CRC.